A Recombinant Blood‐Stage Malaria Vaccine ReducesPlasmodium falciparumDensity and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New Guinea
Top Cited Papers
Open Access
- 15 March 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (6) , 820-827
- https://doi.org/10.1086/339342
Abstract
The malaria vaccine Combination B comprises recombinant Plasmodium falciparum ring-infected erythrocyte surface antigen and 2 merozoite surface proteKeywords
This publication has 0 references indexed in Scilit: